Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03805841
Title Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (RAIN)
Acronym RAIN
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rain Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
RAIN-701 Study Site Irvine California 92697 United States Details
Pacific Shores Medical Group Long Beach California 90813 United States Details
University of California San Francisco, Helen Diller Cancer Center San Francisco California 94158 United States Details
RAIN-701 Study Site Aurora Colorado 80045 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Comprehensive Care and Research Center, Atlanta Newnan Georgia 30265 United States Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
Providence Cancer Institute Portland Oregon 97213 United States Details
RAIN-701 Study Site Pittsburgh Pennsylvania 15232 United States Details
RAIN-701 Study Site Seattle Washington 98109 United States Details
RAIN-701 Study Site Toronto Ontario M5G 2C1 Canada Details
RAIN-701 Study Site Hong Kong Hong Kong Details
Hong Kong United Oncology Center Kowloon Hong Kong Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field